11 May 2023 - Pfizer Chief Executive Albert Bourla called US plans to negotiate drug prices for its Medicare health program "negotiation with a gun to your head" and said he expects drug makers to sue in an attempt to halt the process.

"It is not negotiation at all. It is price setting," Bourla said at a Reuters newsmaker event on Thursday, referring to the Biden Administration’s signature drug pricing reform, part of the Inflation Reduction Act. The law aims to save $25 billion through price negotiations by 2031 for Americans who pay more for medicines than any other country.

Read Reuters article